Plus Therapeutics, Inc.
NASDAQ: PSTV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Marc H. Hedrick
- Employees
- 21
- Headquarters
- Austin, United States
- IPO year
- 2001
- Market cap
- $9.6M
- Website
- https://www.plustherapeutics.com
Loading PSTV…
Loading profile data…Frequently asked questions about PSTV
What does Plus Therapeutics, Inc. (PSTV) do?
Plus Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, dedicated to the development, manufacturing, and market introduction of therapeutic solutions for cancer patients and individuals with other serious illnesses. A cornerstone of their pipeline is Rhenium-186 NanoLiposome (R-186 NL), a patented radiotherapy specifically e...
Where does PSTV trade?
Plus Therapeutics, Inc. (PSTV) trades on the NASDAQ Capital Market.
What sector is PSTV in?
Plus Therapeutics, Inc. (PSTV) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Plus Therapeutics, Inc.?
Marc H. Hedrick is the chief executive officer of Plus Therapeutics, Inc. (PSTV).
Where is Plus Therapeutics, Inc. headquartered?
Plus Therapeutics, Inc. is headquartered in United States.
Does PSTV pay a dividend?
Plus Therapeutics, Inc. (PSTV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSTV go public?
Plus Therapeutics, Inc. (PSTV) completed its initial public offering in 2001.